Determination of the Optimal Cut Off Value of the Modified Ashworth Scale in the Evaluation of Gait Performance and Functional Mobility in Individuals with Cerebral Palsy
Launched by INONU UNIVERSITY · Feb 9, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to best evaluate walking performance and mobility in children with cerebral palsy (CP), particularly those with the spastic type, which is the most common form of CP. Researchers are using a tool called the Modified Ashworth Scale to measure muscle tone and stiffness, which affects how well these children can move and walk. The goal is to determine the best cutoff values on this scale to help assess each child's movement abilities more accurately.
To participate in the study, children aged 6 to 15 who have a certain level of mobility and can understand the tests will be included. However, those who have had recent surgeries on their legs, serious skin issues, or specific medical treatments will not be eligible. Participants can expect to undergo assessments that will help researchers understand more about their mobility and how it relates to muscle tone. This study is currently recruiting and aims to improve the care and evaluation methods for children with CP.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • GMFSS:1-2,
- • Have the appropriate cognitive level to adapt to the tests to be performed in the study,
- • Individuals between the ages of 6-15 who agreed to participate in the study were included.
- Exclusion Criteria:
- • Bone and/or soft tissue surgery on the lower extremities within the last 1 year who had the operation,
- • Extensive serious skin injuries, skin infection,
- • Lower extremity MAS score \> 2,
- • Mental retardation,
- • Individuals who had botulinum toxin applied to their lower extremities within the last 1 year were excluded.
About Inonu University
Inonu University is a prominent academic institution located in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient care and advancing scientific knowledge. With a strong commitment to ethical standards and regulatory compliance, Inonu University collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous clinical trials that contribute to the development of new therapies and treatment modalities. Through its research endeavors, the university strives to enhance healthcare outcomes and foster a culture of inquiry within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported